Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001110792.2(MECP2):c.488A>G (p.Asp163Gly)

Curation Version - 2.0
Curation History
JSON LD for Version 2.0

CA270421

143578 (ClinVar)

Gene: MECP2

Condition: Rett syndrome

Inheritance Mode: X-linked inheritance

Link to MONDO

UUID: b6d47811-23c9-458c-b9ae-f33311d4bb97

Approved on: 2023-10-13

Published on: 2023-12-08

HGVS expressions

NM_001110792.2:c.488A>G

NM_001110792.2(MECP2):c.488A>G (p.Asp163Gly)

NC_000023.11:g.154031376T>C

CM000685.2:g.154031376T>C

NC_000023.10:g.153296827T>C

CM000685.1:g.153296827T>C

NC_000023.9:g.152950021T>C

NG_007107.2:g.110752A>G

NG_007107.3:g.110728A>G

ENST00000303391.11:c.452A>G

ENST00000453960.7:c.488A>G

ENST00000637917.1:c.65+20A>G

ENST00000303391.10:c.452A>G

ENST00000369957.5:c.*506A>G

ENST00000407218.5:c.468+20A>G

ENST00000453960.6:c.488A>G

ENST00000486506.5:n.2800A>G

ENST00000611468.1:c.440A>G

ENST00000619732.4:c.452A>G

ENST00000622433.4:c.440A>G

ENST00000628176.2:c.432+20A>G

NM_001110792.1:c.488A>G

NM_001316337.1:c.173A>G

NM_004992.3:c.452A>G

NM_001316337.2:c.173A>G

NM_001369391.2:c.173A>G

NM_001369392.2:c.173A>G

NM_001369393.2:c.173A>G

NM_001369394.1:c.173A>G

NM_001369394.2:c.173A>G

NM_001386137.1:c.-129+20A>G

NM_001386138.1:c.-129+20A>G

NM_001386139.1:c.-129+20A>G

NM_004992.4:c.452A>G

Likely Pathogenic

PM2_Supporting PS4_Moderate PP4 PP3 PM1

Evidence Links 1

Expert Panel

Rett and Angelman-like Disorders VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Rett and Angelman-like Disorders VCEP

The p.Asp151Gly variant in MECP2 (NM_004992.3) has been reported in an individual with a clinical phenotype suggestive of Rett syndrome (PMID 15173251) (PP4). The p.Asp151Gly variant has been observed in at least 3 other individuals with atypical Rett syndrome or clinical features of Rett syndrome (PMID 15173251, 32472557, internal database - University of Chicago, internal database - Invitae) (PS4_Moderate). The p.Asp151Gly variant occurs in the well-characterized Methyl-DNA binding (MDB) functional domain of MECP2 (PM1). The p.Asp151Gly variant in MECP2 is absent from gnomAD (PM2_Supporting). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). In summary, the p.Asp151Gly variant in MECP2 is classified as Likely Pathogenic based on the ACMG/AMP criteria (PS4_moderate, PM1, PM2_supporting, PP3, PP4).

PM2_Supporting

The p.Asp151Gly variant in MECP2 is absent from gnomAD

PS4_Moderate

The p.Asp151Gly variant has been observed in at least 3 other individuals with either atypical Rett syndrome or clinical features of Rett syndrome (PMID 15173251, 32472557, internal database - University of Chicago, internal database - Invitae) (PS4_moderate).

PS4_supporting PubMed:12180070

PP4

The p.Asp151Gly variant in MECP2 (NM_004992.3) has been reported in an individual with a clinical phenotype suggestive of Rett syndrome (PMID 15173251) (PP4).

PP3

Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own

PM1

The p.Asp151Gly variant occurs in the well-characterized Methyl-DNA binding (MDB) functional domain of MECP2

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.